Professor, Department of Anesthesia, UCSF
Additional Websites
Education
Princeton University, B.A., June 1990, Molecular Biology and Biochemical Sciences
University of California, San Francisco, Ph.D., Dec. 1994, Biochemistry and Biophysics
Professional Experience
-
1995-1997
Visiting fellow, Department of Dermatology, University of California school of medicine, San Francisco, California
-
1998-2001
Visiting fellow, Department of Anesthesia and Pharmaceutical chemistry, San Francisco General Hospital, San Francisco, California.
-
2002-2006
Assistant Professor, Department of Anesthesia, University of California, San Francisco.
-
2006-2011
Associate Professor, Department of Anesthesia, University of California, San Francisco.
-
2011-present
Professor, Department of Anesthesia, University of California, San Francisco.
-
2003-present
Program member, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.
Honors & Awards
- 1990
Summa Cum Laude (Princeton University) - 1990
Phi Beta Kappa (Princeton University) - 1990
Sigma Xi (Princeton University) - 1990
Sigma Xi Book Award (Princeton University) - 1990
E.R. Squibb and Sons Thesis Prize (Princeton University) - 1990
George Khoury’65 Prize For Academic Excellence (Princeton University) - 1990,1991
Regents’ Fellow (University of California at San Francisco) - 1994
Chancellor's Fellow (University of California at San Francisco) - 1996-1999
SmithKline Beecham Fellow of the Life Sciences Research Foundation - 1998
Scleroderma Research Foundation investigator award - 2002
American Cancer Society intramural research award - 2002
BioSTAR/UC Discovery award - 2002
CaPCure research award - 2002
DOD New Investigator award - 2004
MARF Investigator award - 2006
MARF Investigator award - 2008
AACR PanCan Pilot award - 2009
UC Discovery SEED award - 2011
MARF Investigator award
Selected Publications
- McCabe KE, Liu B, Marks JD, Tomlinson JS, Wu H, Wu AM. An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors. Mol Imaging Biol. 2012 Jun; 14(3):336-47.
View on PubMed - Iyer AK, Lan X, Zhu X, Su Y, Feng J, Zhang X, Gao D, Seo Y, Vanbrocklin HF, Broaddus VC, Liu B, He J. Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas. Cancer Res. 2011 Apr 1; 71(7):2428-32.
View on PubMed - Iyer AK, Su Y, Feng J, Lan X, Zhu X, Liu Y, Gao D, Seo Y, Vanbrocklin HF, Courtney Broaddus V, Liu B, He J. The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma. Biomaterials. 2011 Apr; 32(10):2605-13.
View on PubMed - Bidlingmaier S, Liu B. Identification of protein/target molecule interactions using yeast surface-displayed cDNA libraries. Methods Mol Biol. 2011; 729:211-23.
View on PubMed - Bidlingmaier S, Liu B. Construction of yeast surface-displayed cDNA libraries. Methods Mol Biol. 2011; 729:199-210.
View on PubMed - Bidlingmaier S, Wang Y, Liu Y, Zhang N, Liu B. Comprehensive analysis of yeast surface displayed cDNA library selection outputs by exon microarray to identify novel protein-ligand interactions. Mol Cell Proteomics. 2011 Mar; 10(3):M110.005116.
View on PubMed - Chen Y, Zhu X, Zhang X, Liu B, Huang L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther. 2010 Sep; 18(9):1650-6.
View on PubMed - Zhu X, Bidlingmaier S, Hashizume R, James CD, Berger MS, Liu B. Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells. Mol Cancer Ther. 2010 Jul; 9(7):2131-41.
View on PubMed - He J, Wang Y, Feng J, Zhu X, Lan X, Iyer AK, Zhang N, Seo Y, VanBrocklin HF, Liu B. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. J Nucl Med. 2010 Mar; 51(3):427-32.
View on PubMed - Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, Gabriel BS, Hann B, Liu B, Park JW, Hong K, Benz CC, Marks JD, Kirpotin DB. Development of a highly stable and targetable nanoliposomal formulation of topotecan. J Control Release. 2010 Jan 4; 141(1):13-21.
View on PubMed - Conrad F, Zhu X, Zhang X, Chalkley RJ, Burlingame AL, Marks JD, Liu B. Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion. J Mol Med (Berl). 2009 May; 87(5):507-14.
View on PubMed - Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B. Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res. 2009 Feb 15; 69(4):1570-7.
View on PubMed - Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl). 2008 Sep; 86(9):1025-32.
View on PubMed - An F, Drummond DC, Wilson S, Kirpotin DB, Nishimura SL, Broaddus VC, Liu B. Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies. Mol Cancer Ther. 2008 Mar; 7(3):569-78.
View on PubMed - Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, Benz CC, Marks JD, Liu B. Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Mol Cancer Ther. 2007 Oct; 6(10):2737-46.
View on PubMed - Liu B. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA. Brief Funct Genomic Proteomic. 2007 Jun; 6(2):112-9.
View on PubMed - Bidlingmaier S, Liu B. Interrogating yeast surface-displayed human proteome to identify small molecule-binding proteins. Mol Cell Proteomics. 2007 Nov; 6(11):2012-20.
View on PubMed - Liu B, Conrad F, Roth A, Drummond DC, Simko JP, Marks JD. Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer. J Mol Med (Berl). 2007 Oct; 85(10):1113-23.
View on PubMed - Goenaga AL, Zhou Y, Legay C, Bougherara H, Huang L, Liu B, Drummond DC, Kirpotin DB, Auclair C, Marks JD, Poul MA. Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Mol Immunol. 2007 Jul; 44(15):3777-88.
View on PubMed - Ruan W, Sassoon A, An F, Simko JP, Liu B. Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection. Mol Cell Proteomics. 2006 Dec; 5(12):2364-73.
View on PubMed
View on UCSF Profiles
